Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Holt

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Drug and Alcohol Dependence|January 10, 2018
Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 studyMandy J Hill, Michael Holt, Brett Hanscom, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 11, 2007
Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based techniqueThanh G Phan, Geoffrey A Donnan, Masatoshi Koga, et al.
Neuroimage|March 1, 2006
The ASPECTS template is weighted in favor of the striatocapsular regionThanh G Phan, Geoffrey A Donnan, Masatoshi Koga, et al.
Immunity & Ageing : I & A|February 23, 2022
CD161 expression defines new human γδ T cell subsetsAmali Karunathilaka, Samuel Halstrom, Patricia Price, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 4, 2013
Dimensions of subcortical infarcts associated with first- to third-order branches of the basal ganglia arteriesThanh G Phan, Sanne van der Voort, Richard Beare, et al.
Frontiers in Oncology|May 5, 2020
Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant TherapyChad A Barnes, Mohammed Aldakkak, Callisia N Clarke, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Drug and Alcohol Dependence|January 10, 2018
Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 studyMandy J Hill, Michael Holt, Brett Hanscom, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 11, 2007
Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based techniqueThanh G Phan, Geoffrey A Donnan, Masatoshi Koga, et al.
Neuroimage|March 1, 2006
The ASPECTS template is weighted in favor of the striatocapsular regionThanh G Phan, Geoffrey A Donnan, Masatoshi Koga, et al.
Immunity & Ageing : I & A|February 23, 2022
CD161 expression defines new human γδ T cell subsetsAmali Karunathilaka, Samuel Halstrom, Patricia Price, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 4, 2013
Dimensions of subcortical infarcts associated with first- to third-order branches of the basal ganglia arteriesThanh G Phan, Sanne van der Voort, Richard Beare, et al.
Frontiers in Oncology|May 5, 2020
Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant TherapyChad A Barnes, Mohammed Aldakkak, Callisia N Clarke, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 2